Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04379024 · ClinicalTrials.gov registry record · Early Phase 1
Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms
A Early Phase 1 study, sponsored by Carol Fabian, MD.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
NCT04379024: Clinical Trial Early Phase 1 study, sponsored by Carol Fabian, MD.
NCT04379024 is a Early Phase 1 study that was terminated before completion, run by Carol Fabian, MD. The registered enrollment target is 11 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04379024, a Early Phase 1 study, was terminated before completion, sponsored by Carol Fabian, MD.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
Pilot study to test feasibility of 6 months of Duavee® vs wait-list control in post-menopausal women symptomatic for hot flashes.
Primary Outcome
Trial design is acceptable to potential subjects, as evidenced by participation
Interventions
- DRUG DUAVEE 0.45Mg-20Mg Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2020-06-01 |
| Est. Completion | 2021-07-31 |
| Phase | Early Phase 1 |
Why NCT04379024 stopped before completion
NCT04379024 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 1 intervention - of which DUAVEE 0.45Mg-20Mg Tablet is the first listed.
NCT04379024 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04379024 about?
NCT04379024 is a clinical study titled "Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms". Pilot study to test feasibility of 6 months of Duavee® vs wait-list control in post-menopausal women symptomatic for hot flashes.
What is the current status of trial NCT04379024?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2020-06-01. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT04379024?
The interventions under investigation include: DUAVEE 0.45Mg-20Mg Tablet (DRUG).
Who is sponsoring clinical trial NCT04379024?
This trial is sponsored by Carol Fabian, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04379024's enrollment target sits among peer trials
11 1600th of 2000 higher than 373 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI